Vol 92, No 1 (2021)
Clinical vignette
Published online: 2021-01-25
Successful perinatal management and pacemaker stimulation during the first hour of life in a 1.6 kg newborn with autoimmune congenital complete heart block diagnosed prenatally
1
, 2, 2, 1, 3
, 2, 2, 1, 3
Abstract
Not available
Keywords: congenital heart blockSjogren’s syndromeautoantibodiespacemaker
References
- Bordachar P, Zachary W, Ploux S, et al. Pathophysiology, clinical course, and management of congenital complete atrioventricular block. Heart Rhythm. 2013; 10(5): 760–766.
- Wainwright B, Bhan R, Trad C, et al. Autoimmune-mediated congenital heart block. Best Pract Res Clin Obstet Gynaecol. 2020; 64: 41–51.
- Skog A, Lagnefeldt L, Conner P, et al. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block. Acta Obstet Gynecol Scand. 2016; 95(1): 98–105.
- Buyon JP, Hiebert R, Copel J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998; 31(7): 1658–1666.
- Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation. 2012; 126(1): 76–82.
- Glatz AC, Gaynor JW, Rhodes LA, et al. Outcome of high-risk neonates with congenital complete heart block paced in the first 24 hours after birth. J Thorac Cardiovasc Surg. 2008; 136(3): 767–773.
- Julkunen H, Eronen M. The rate of recurrence of isolated congenital heart block: a population-based study. Arthritis Rheum. 2001; 44(2): 487–488, doi: 10.1002/1529-0131(200102)44:2<487::AID-ANR70>3.0.CO;2-D.
- Brito-Zerón P, Izmirly PM, Ramos-Casals M, et al. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol. 2015; 11(5): 301–312.
- Costedoat-Chalumeau N, Georgin-Lavialle S, Amoura Z, et al. Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block. Lupus. 2005; 14(9): 660–664.
- Jaeggi ET, Hamilton RM, Silverman ED, et al. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years. J Am Coll Cardiol. 2002; 39(1): 130–137.
- Michaëlsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation. 1995; 92(3): 442–449.
- Buyon JP, Hiebert R, Copel J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998; 31(7): 1658–1666.
- Jaeggi ET, Hamilton RM, Silverman ED, et al. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years. J Am Coll Cardiol. 2002; 39(1): 130–137.
- Von Sc, Fink C, Peuster M, et al. Permanent pacemaker implantation in a 1445 g preterm neonate on the first day of life. J Thorac Cardiovasc Surg. 2002; 50: 360–366.
- Donofrio MT, Gullquist SD, Mehta ID, et al. Congenital complete heart block: fetal management protocol, review of the literature, and report of the smallest successful pacemaker implantation. J Perinatol. 2004; 24(2): 112–117.
- Maeno Y, Himeno W, Saito A, et al. Clinical course of fetal congenital atrioventricular block in the Japanese population: a multicentre experience. Heart. 2005; 91(8): 1075–1079.
